Proteomic analysis reveals brain Rab35 as a potential biomarker of mitragynine withdrawal in rats.

Brain Res Bull

Centre for Drug Research, Universiti Sains Malaysia, 11800, Minden, Penang, Malaysia; Addiction Behaviour and Neuroplasticity Laboratory, National Neuroscience Institute, 11 Jalan Tan Tock Seng, 308433, Singapore. Electronic address:

Published: July 2021

Mitragyna speciosa, also known as kratom, has been used for mitigating the severity of opioid withdrawal in humans. Its main indole alkaloid, mitragynine, has been considered as a pharmacotherapy for pain conditions and opioid replacement therapy. However, at high doses, chronic mitragynine may also have an addiction potential. The effects of chronic action of mitragynine in the brain are still unknown. The present study developed a mitragynine withdrawal model in rats and used it for a proteomic analysis of mitragynine withdrawal effects. Mitragynine (30 mg/kg, i.p.) was administered daily over a period of 14 days and then withdrawn. A proteomic analysis revealed that from a total of 1524 proteins identified, 31 proteins were upregulated, and 3 proteins were downregulated in the mitragynine withdrawal model. The Rab35 protein expression increased most profoundly in the mitragynine withdrawal group as compared to vehicle group. Therefore, it is proposed that Rab35 in the brain might be considered as a potential biomarker during mitragynine withdrawal and might be valuable target protein in developing new pharmacotherapies in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.brainresbull.2021.04.018DOI Listing

Publication Analysis

Top Keywords

mitragynine withdrawal
24
proteomic analysis
12
mitragynine
10
potential biomarker
8
biomarker mitragynine
8
withdrawal model
8
withdrawal
7
analysis reveals
4
reveals brain
4
brain rab35
4

Similar Publications

The neuropharmacology of kratom, a novel psychoactive natural product.

Prog Neuropsychopharmacol Biol Psychiatry

December 2024

College of Pharmacy, Department of Pharmaceutical Sciences, Midwestern University, Glendale, AZ, United States; College of Pharmacy, Department of Medicinal Chemistry, University of Florida, Gainesville, FL, United States. Electronic address:

Kratom (Mitragyna speciosa, Korth.) is a tropical tree that is indigenous to Southeast Asia. When ingested, kratom leaves or decoctions from the leaves have been reported to produce complex stimulant and opioid-like effects.

View Article and Find Full Text PDF

Quantification of 11 kratom alkaloids including mitragynine and its main metabolites in human plasma using LC-MS/MS.

Anal Bioanal Chem

December 2024

iC42 Clinical Research and Development, Department of Anesthesiology, Anschutz Medical Campus, University of Colorado, 12705 E Montview Blvd, Suite 200, Aurora, CO, 80045, USA.

Recently in the USA, kratom consumers increasingly report use of the plant for self-treatment of mood ailments, the lack of energy, chronic pain, and opioid withdrawal and dependence. Several alkaloids are present in kratom leaves, but limited data are available on their pharmacokinetics/pharmacodynamics, except for mitragynine. To support clinical studies, a high-performance liquid chromatography-tandem mass spectrometry assay for the simultaneous quantification of 11 kratom alkaloids in human plasma was developed and validated.

View Article and Find Full Text PDF

Kratom Alkaloids for the Treatment of Alcohol Use Disorder.

ACS Chem Neurosci

December 2024

Department of Pharmacological & Pharmaceutical Sciences, College of Pharmacy, University of Houston, Houston, Texas 77204, United States.

Article Synopsis
  • Alcohol use disorder (AUD) leads to significant mortality and economic costs, with limited FDA/EMA-approved treatments available, many of which have adverse effects.
  • Kratom alkaloids show promise in reducing alcohol intake and withdrawal symptoms in animal studies by acting on specific opioid receptors.
  • The article reviews recent preclinical studies on kratom for AUD treatment, discusses approved and repurposed drugs, and outlines caveats and future research needs.
View Article and Find Full Text PDF
Article Synopsis
  • Kratom is a plant from Southeast Asia that some people in the U.S. use to help with pain and getting off stronger drugs like opioids.
  • A 56-year-old man, who had stopped using Kratom suddenly, became very agitated and aggressive, leading him to the hospital.
  • Doctors found out that his crazy behavior was caused by Kratom withdrawal, which is a rare but serious condition that hasn't been reported like this before.
View Article and Find Full Text PDF

Beneficial and adverse health effects of kratom (Mitragyna speciosa): A critical review of the literature.

Food Chem Toxicol

October 2024

Paustenbach and Associates, 970 West Broadway, Suite E, Jackson, WY, USA.

Article Synopsis
  • Kratom, derived from the Mitragyna speciosa plant, has been used in Southeast Asia for a long time and has recently gained popularity in the U.S. for its stimulant and pain-relieving effects, largely due to its key alkaloids mitragynine and 7-hydroxymitragynine.
  • Its potential benefits include use as a reduced-harm alternative to opioids and as a treatment for withdrawal, but there are also concerns about tolerance and addiction, especially when combined with other substances.
  • Current research highlights both the therapeutic potentials and risks of kratom but points out the need for more studies to better understand the safe dosing and potential adverse effects in humans and animals.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!